Physician profile

Gary G Sauer

Family Medicine · Mc Kees Rocks, PA

NPI 1619969672

$3,213.83

in general payments reported to CMS, 2019-2025

32 companies · $506 in 2025

The $506 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,475.66

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Glaxosmithkline, LLC. $438.70 2019-2025 Trelegy Ellipta, Shingrix, Flulaval Quadrivalent
Abbvie INC. $336.33 2021-2025 Qulipta, Vraylar
Novo Nordisk INC $294.73 2019-2025 Ozempic, Wegovy, Rybelsus
Astrazeneca Pharmaceuticals LP $236.42 2019-2025 Farxiga, Airsupra
Boehringer Ingelheim Pharmaceuticals, INC. $185.21 2019-2023 Jardiance, Tradjenta
Lilly USA, LLC $178.95 2019-2023 Mounjaro
Janssen Pharmaceuticals, INC $160.49 2019-2025 Spravato
Pfizer INC. $159.84 2019-2025
Amgen INC. $148.28 2019-2025 Repatha, Otezla, Repatha
Edwards Lifesciences Corporation $122.44 2023-2025
Merck Sharp & Dohme LLC $104.52 2019-2023 Verquvo, Steglatro, Belsomra
Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) $79.57 2025 Caplyta
Abiomed $69.10 2023-2024 Impella
Novartis Pharmaceuticals Corporation $63.57 2022-2023
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $61.66 2019-2022
Show all 32 companies
CompanyGeneral paymentsYearsTop products
Takeda Pharmaceuticals U.S.A., INC. $60.56 2020-2021
Sanofi-Aventis U.S. LLC $56.64 2021-2025
Amarin Pharma, INC. $55.21 2020-2021
Eisai INC. $42.10 2024
Astellas Pharma US INC $41.92 2023-2024 Veozah
Biohaven Pharmaceuticals, INC. $41.56 2021
Xeris Pharmaceuticals, INC. $37.73 2024 Gvoke Hypopen
Sanofi Pasteur INC. $37.23 2025
Bayer Healthcare Pharmaceuticals INC. $32.23 2022-2023
Gilead Sciences, INC. $30.58 2019-2021
Phathom Pharmaceuticals, INC. $28.15 2024 Voquezna
Biohaven Pharmaceutical Holding Company LTD. $26.63 2022
Stryker Corporation $19.84 2025 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Vyera Pharmaceuticals, LLC $16.97 2021
Abbott Laboratories $15.74 2023 Freestyle Libre 3
Teva Pharmaceuticals USA, INC. $15.57 2020
Kowa Pharmaceuticals America, INC. $15.36 2025 Zoryve

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Gary G Sauer

$3,213.83

in general payments reported 2019-2025

Years
2019-2025
Top company
Glaxosmithkline, LLC.
Context
The $506 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).

https://glasscript.com/doctor/345478/gary-g-sauer

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.